These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 9178165)

  • 1. Glutamate, excitotoxicity and amyotrophic lateral sclerosis.
    Shaw PJ; Ince PG
    J Neurol; 1997 May; 244 Suppl 2():S3-14. PubMed ID: 9178165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular mechanism of glutamate receptors in relation to amyotrophic lateral sclerosis.
    Iwasaki Y; Ikeda K; Kinoshita M
    Curr Drug Targets CNS Neurol Disord; 2002 Oct; 1(5):511-8. PubMed ID: 12769603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitotoxicity and amyotrophic lateral sclerosis.
    Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
    Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
    Cheah BC; Vucic S; Krishnan AV; Kiernan MC
    Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glutamate hypothesis in ALS: pathophysiology and drug development.
    Blasco H; Mavel S; Corcia P; Gordon PH
    Curr Med Chem; 2014; 21(31):3551-75. PubMed ID: 25245510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole and ALS therapy.
    Hugon J
    Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cortico-motoneuron vulnerability after chronic mitochondrial inhibition in vitro and the role of glutamate receptors.
    Van Westerlaak MG; Joosten EA; Gribnau AA; Cools AR; Bär PR
    Brain Res; 2001 Dec; 922(2):243-9. PubMed ID: 11743956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium dysregulation in amyotrophic lateral sclerosis.
    Grosskreutz J; Van Den Bosch L; Keller BU
    Cell Calcium; 2010 Feb; 47(2):165-74. PubMed ID: 20116097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of riluzole in ALS CSF toxicity.
    Couratier P; Sindou P; Esclaire F; Louvel E; Hugon J
    Neuroreport; 1994 Apr; 5(8):1012-4. PubMed ID: 8061281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis, excitotoxicity and riluzole.
    Obrenovitch TP
    Trends Pharmacol Sci; 1998 Jan; 19(1):9-11. PubMed ID: 9509893
    [No Abstract]   [Full Text] [Related]  

  • 12. Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block.
    Cifra A; Nani F; Nistri A
    Eur J Neurosci; 2011 Mar; 33(5):899-913. PubMed ID: 21324003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
    Kwak S; Kawahara Y
    J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis.
    Shaw PJ; Eggett CJ
    J Neurol; 2000 Mar; 247 Suppl 1():I17-27. PubMed ID: 10795883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
    Bellingham MC
    CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole: what it does to spinal and brainstem neurons and how it does it.
    Cifra A; Mazzone GL; Nistri A
    Neuroscientist; 2013 Apr; 19(2):137-44. PubMed ID: 22596264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riluzole for amyotrophic lateral sclerosis.
    Med Lett Drugs Ther; 1995 Dec; 37(963):113-4. PubMed ID: 7500908
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of AMPA receptors and VEGF in ALS.
    Van Damme P
    Verh K Acad Geneeskd Belg; 2009; 71(4):241-50. PubMed ID: 20084835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis.
    Corona JC; Tovar-y-Romo LB; Tapia R
    Expert Opin Ther Targets; 2007 Nov; 11(11):1415-28. PubMed ID: 18028007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of excitotoxicity in neurodegenerative disease: implications for therapy.
    Doble A
    Pharmacol Ther; 1999 Mar; 81(3):163-221. PubMed ID: 10334661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.